Page last updated: 2024-11-05

tranexamic acid and Heart Septal Defects, Ventricular

tranexamic acid has been researched along with Heart Septal Defects, Ventricular in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.

Research Excerpts

ExcerptRelevanceReference
"Glanzmann thrombasthenia is a rare congenital platelet disorder characterized by spontaneous mucocutaneous bleeding and severe bleeding complications during major surgery."1.35Perioperative haemostatic management of Glanzmann thrombasthenia for abdominal surgery. ( Heindl, B; Lison, S; Spannagl, M, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lison, S1
Spannagl, M1
Heindl, B1

Other Studies

1 other study available for tranexamic acid and Heart Septal Defects, Ventricular

ArticleYear
Perioperative haemostatic management of Glanzmann thrombasthenia for abdominal surgery.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2009, Volume: 20, Issue:5

    Topics: Adult; Antifibrinolytic Agents; Blood Coagulation Tests; Blood Loss, Surgical; Blood Transfusion, Au

2009